Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →24
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,109
Total Claims
$2.2M
Drug Cost
557
Beneficiaries
$4,011
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 516 Osteopathic Manipulative Medicine providers
-91%
Opioid rate vs peers
0.7% vs 7.5% avg
+263%
Cost per patient vs peers
$4,011 vs $1,104 avg
+129%
Brand preference vs peers
17.0% vs 7.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.7%
Opioid Rate
98
Opioid Claims
$631
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,350 claims · $1.9M
Generic: 11,493 claims · $333K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 429 | $288K |
| Romosozumab-Aqqg | 100 | $241K |
| Empagliflozin | 162 | $199K |
| Denosumab | 118 | $191K |
| Sitagliptin Phosphate | 127 | $116K |
| Tenofovir Alafenamide | 58 | $87K |
| Dapagliflozin Propanediol | 87 | $66K |
| Cyclosporine | 55 | $61K |
| Rivaroxaban | 64 | $60K |
| Lipase/Protease/Amylase | 45 | $57K |
| Linagliptin | 45 | $44K |
| Semaglutide | 23 | $42K |
| Rsvpref3 Antigen/As01e/Pf | 125 | $37K |
| Apixaban | 36 | $33K |
| Dulaglutide | 27 | $33K |
Prescribing Profile
Patient Profile
73
Avg Age
46%
Female
1.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About